This report shows patients by high and moderate risk as defined by ATAGI and utilised in the national roadmap.

It uses the same categories as the 'General' COVID-19 report:

• Dose 1 Categories
  • Dose 1 Astrazeneca (Vaxzevria) 
  • Dose 1 Pfizer (Comirnaty)
  • Dose 1 Moderna (Spikevax)
  • Dose 1 Unknown
• Dose 2 Categories
  • Dose 2 Astrazeneca (Vaxzevria)
  • Dose 2 Pfizer (Comirnaty)
  • Dose 2 Moderna (Spikevax)
  • Dose 2 Unknown
• Declined 
• Not Recorded

But in this report only patients with underlying risk factors are reported along with their vaccine status.